JP2024518000A5 - - Google Patents

Info

Publication number
JP2024518000A5
JP2024518000A5 JP2024513163A JP2024513163A JP2024518000A5 JP 2024518000 A5 JP2024518000 A5 JP 2024518000A5 JP 2024513163 A JP2024513163 A JP 2024513163A JP 2024513163 A JP2024513163 A JP 2024513163A JP 2024518000 A5 JP2024518000 A5 JP 2024518000A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
pharmaceutically acceptable
acceptable salt
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024513163A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518000A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/026715 external-priority patent/WO2022232383A1/en
Publication of JP2024518000A publication Critical patent/JP2024518000A/ja
Publication of JP2024518000A5 publication Critical patent/JP2024518000A5/ja
Pending legal-status Critical Current

Links

JP2024513163A 2021-04-30 2022-04-28 グルコセレブロシダーゼ活性の小分子モジュレータ及びその使用 Pending JP2024518000A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163182728P 2021-04-30 2021-04-30
US63/182,728 2021-04-30
PCT/US2022/026715 WO2022232383A1 (en) 2021-04-30 2022-04-28 Small molecule modulators of glucocerebrosidase activity and uses thereof

Publications (2)

Publication Number Publication Date
JP2024518000A JP2024518000A (ja) 2024-04-23
JP2024518000A5 true JP2024518000A5 (cg-RX-API-DMAC7.html) 2025-05-09

Family

ID=83848834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024513163A Pending JP2024518000A (ja) 2021-04-30 2022-04-28 グルコセレブロシダーゼ活性の小分子モジュレータ及びその使用

Country Status (10)

Country Link
US (1) US20240262832A1 (cg-RX-API-DMAC7.html)
EP (1) EP4329881A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024518000A (cg-RX-API-DMAC7.html)
KR (1) KR20240005805A (cg-RX-API-DMAC7.html)
CN (1) CN117642404A (cg-RX-API-DMAC7.html)
AU (1) AU2022265691A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023022524A2 (cg-RX-API-DMAC7.html)
CA (1) CA3218259A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023012882A (cg-RX-API-DMAC7.html)
WO (1) WO2022232383A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7677983B2 (ja) 2020-01-23 2025-05-15 マイオフォルテ セラピューティクス,インク. Pgdh阻害剤、およびその作製と使用の方法
CA3235270A1 (en) * 2021-10-13 2023-04-20 Vanqua Bio, Inc. Small molecule modulators of glucocerebrosidase activity and uses thereof
US20250230172A1 (en) * 2021-10-13 2025-07-17 Vanqua Bio, Inc. Small molecule modulators of glucocerebrosidase activity and uses thereof
CN121218985A (zh) * 2022-12-08 2025-12-26 森雅制药有限公司 Sarm1抑制剂、药物组合物和治疗应用
WO2024158931A1 (en) * 2023-01-25 2024-08-02 Epirium Bio Inc. Pgdh inhibitors and methods of making and using
WO2025171259A1 (en) * 2024-02-09 2025-08-14 Board Of Regents Of The University Of Nebraska Compounds, compositions, and methods for the treatment of diseases
WO2025237303A1 (zh) * 2024-05-14 2025-11-20 先声药业有限公司 β-葡萄糖脑苷脂酶变构调节剂、其药物组合物及用途
WO2025244978A1 (en) * 2024-05-20 2025-11-27 The General Hospital Corporation Compounds for targeting ulk3 and uses of the same

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4088652A (en) * 1975-07-31 1978-05-09 American Cyanamid Company Acylazabicyclohexanes
JPH0240671B2 (ja) * 1982-02-05 1990-09-12 Lion Corp 11fueniruu1hhpirazoro*3*44b*pirajinjudotai
AUPQ105499A0 (en) * 1999-06-18 1999-07-08 Biota Scientific Management Pty Ltd Antiviral agents
US7294637B2 (en) * 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
US6995144B2 (en) * 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
CA2507348C (en) * 2004-05-13 2013-07-16 The Hospital For Sick Children Real time methylumbelliferone-based assay
FR2887549B1 (fr) * 2005-06-23 2009-07-10 Centre Nat Rech Scient Nouveaux composes de la famille des iminosucres, leurs utilisations, notamment pour le traitement de maladies lysosomales, ainsi que leur procede de preparation
US20100222353A1 (en) * 2006-01-27 2010-09-02 Pfizer Products Inc. Aminophthalazine derivative compounds
EP1984351A1 (en) * 2006-02-17 2008-10-29 Memory Pharmaceuticals Corporation Compounds having 5-ht6 receptor affinity
US20100292266A1 (en) * 2006-05-26 2010-11-18 Richard Apodaca Oxazolyl Piperidine Modulators of Fatty Acid Amide Hydrolase
DK2040548T3 (da) * 2006-06-23 2012-08-13 Amicus Therapeutics Inc Fremgangsmåde til behandling af neurologiske forstyrrelser ved forøgelse af aktiviteten af beta-glucocerebrosidase
AU2012200270A1 (en) * 2007-05-23 2012-02-09 Merck Sharp & Dohme Corp. Pyridyl piperidine orexin receptor antagonists
CA2687931C (en) * 2007-05-31 2016-05-24 Boehringer Ingelheim International Gmbh Ccr2 receptor antagonists and uses thereof
CN101952286A (zh) * 2007-12-21 2011-01-19 阿斯利康(瑞典)有限公司 用于治疗和雄激素受体有关的病症的双环衍生物
WO2010010187A1 (en) * 2008-07-25 2010-01-28 Galapagos Nv Novel compounds useful for the treatment of degenerative and inflammatory diseases
WO2010019392A1 (en) * 2008-08-13 2010-02-18 Merck Sharp & Dohme Corp. Purine derivatives for treatment of alzheimer's disease
RU2015147509A (ru) * 2009-10-19 2019-01-14 Амикус Терапьютикс, Инк. Новые композиции для предупреждения и/или лечения дегенеративных расстройств центральной нервной системы
US9051296B2 (en) * 2009-11-16 2015-06-09 Raqualia Pharma Inc. Aryl carboxamide derivatives as TTX-S blockers
WO2012135631A1 (en) * 2011-03-30 2012-10-04 Arrien Pharmaeuticals Llc Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
WO2013075227A1 (en) * 2011-11-25 2013-05-30 The Hospital For Sick Children β-GLUCOCEREBROSIDASE CHAPERONES
JP6454348B2 (ja) * 2013-12-19 2019-01-16 サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. 窒素複素環誘導体およびその医薬品への応用
JP2017502961A (ja) * 2013-12-23 2017-01-26 アレクトス セラピューティックス インコーポレイテッド グルコセレブロシダーゼモジュレーターおよびその使用
US20180185368A1 (en) * 2014-11-06 2018-07-05 Lysosomal Therapeutics Inc. Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
WO2017004408A1 (en) * 2015-07-01 2017-01-05 Northwestern University Substituted 4-methyl-pyrrolo[1.2-a]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
CN108290855A (zh) * 2015-07-01 2018-07-17 西北大学 被取代的喹唑啉化合物及其调节葡糖脑苷脂酶活性的用途
US10154992B2 (en) * 2016-07-12 2018-12-18 The Regents Of The University Of California Compounds and methods for treating HIV infection
EP3661919A4 (en) * 2017-08-02 2021-03-31 Northwestern University SUBSTITUTED FUSION PYRIMIDINE COMPOUNDS AND THEIR USES
JP7052798B2 (ja) * 2017-08-10 2022-04-12 大正製薬株式会社 アゾールで置換されたピリジン化合物
US10961341B2 (en) * 2018-01-30 2021-03-30 Johnson & Johnson Vision Care, Inc. Ophthalmic devices derived from grafted polymeric networks and processes for their preparation and use
US10882865B2 (en) * 2018-08-31 2021-01-05 Northwestern University Pyrrolopyrimidine compounds and uses thereof for modulating glucocerebrosidase activity

Similar Documents

Publication Publication Date Title
RU2594742C2 (ru) Макроциклические соединения в качестве ингибиторов киназы trk
WO2021093758A1 (zh) 一种嘧啶并环衍生物及其在医药上的应用
WO2021249057A1 (zh) 杂环化合物及其用途
CN108148022B (zh) 穿心莲内酯类化合物、其药物组合物及应用
JP6407950B2 (ja) Ship1モジュレーターおよびそれに関連する組成物および方法
CN108623615A (zh) 吡唑[3,4-d]嘧啶-3-酮的大环衍生物、其药物组合物及应用
JP2022507724A (ja) 抗ウイルス剤としての官能化複素環
WO2019143902A2 (en) Substituted heterocycles as antiviral agents
CN109384803B (zh) Atx抑制剂及其制备方法和应用
TW201111385A (en) Heterocyclic compounds as janus kinase inhibitors
CN110028475A (zh) 基于苯并呋喃结构的新型cdk9抑制剂、其制备方法及应用
TW201936572A (zh) 芳基醚及其用途
JP2005535731A5 (cg-RX-API-DMAC7.html)
TW202024093A (zh) 作為抗病毒劑之官能化雜環
JP2013530951A (ja) ヤヌスキナーゼ阻害剤としてのヘテロ環式化合物
TW202527933A (zh) 咪唑-2-酮衍生物及其在醫藥上的應用
CN112028870A (zh) 一种具有苄氧基芳环结构的化合物,其制备方法和用途
CN115867545A (zh) 抗病毒素1,3-二氧代茚化合物
CN118119594A (zh) 一种喜树碱类衍生物中间体、其制备方法和用途
JP2025520541A (ja) コロナウイルス感染症の治療のための化合物
KR20240024906A (ko) 설폭시민 화합물 및 이의 용도
RU2530775C2 (ru) ПРОИЗВОДНЫЕ 1Н-ПИРАЗОЛО[4,3-c]ИЗОХИНОЛИНОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ В ТЕРАПИИ
KR20200112810A (ko) 헤테로아릴 아미드 화합물, 이에 대한 제조 방법, 이의 약학적 조성물 및 이의 적용
ES2432525T3 (es) Pirroles sustituidos terapéuticos
WO2020156522A1 (zh) 地佐辛衍生物及其医药用途